Susquehanna International Group
MIRM icon

Susquehanna International Group’s Mirum Pharmaceuticals MIRM Stock Holding History

Susquehanna International Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.98M Buy
97,200
+71,000
+271% +$6.68M ﹤0.01% 3284
2025
Q4 		$2.07M Sell
26,200
-12,400
-32% -$890K ﹤0.01% 5583
2025
Q3 		$2.83M Buy
38,600
+31,800
+468% +$2.02M ﹤0.01% 5086
2025
Q2 		$346K Buy
+6,800
New +$303K ﹤0.01% 10021
2024
Q4 		– Sell
-13,600
Closed -$530K – 12828
2024
Q3 		$530K Buy
+13,600
New +$543K ﹤0.01% 8316
2024
Q2 		– Sell
-10,400
Closed -$261K – 12788
2024
Q1 		$261K Buy
10,400
+3,300
+46% +$90.7K ﹤0.01% 10024
2023
Q4 		$210K Sell
7,100
-28,900
-80% -$875K ﹤0.01% 10582
2023
Q3 		$1.14M Buy
+36,000
New +$986K ﹤0.01% 6346
2022
Q2 		– Sell
-14,400
Closed -$317K – 13547
2022
Q1 		$317K Buy
14,400
+400
+3% +$8.16K ﹤0.01% 10142
2021
Q4 		$223K Sell
14,000
-10,000
-42% -$156K ﹤0.01% 11215
2021
Q3 		$478K Buy
+24,000
New +$390K ﹤0.01% 9504

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Susquehanna International Group's MIRM Position: Q1 2026 in Review

Susquehanna International Group increased its Mirum Pharmaceuticals (MIRM) stake by 670% in Q1 2026, buying an estimated $1.99M and bringing the position to 24,317 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #5904.

Susquehanna International Group first reported a position in MIRM in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.67M in Q2 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Susquehanna International Group held 24,317 shares of Mirum Pharmaceuticals worth $2.25M as of Q1 2026.
  • Susquehanna International Group bought 21,157 Mirum Pharmaceuticals shares in Q1 2026, an estimated $1.99M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5904 holding.
  • Susquehanna International Group first reported a position in Mirum Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Susquehanna International Group's Mirum Pharmaceuticals position peaked at $2.67M in Q2 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.